Sort
39,280 grants matching “leukemia”
Comparative Analysis of Genetic Interaction Networks
$471,932Trey Ideker · University Of California, San Diego · R01 · FY2015 · GM
Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts
$471,902Vicente Planelles · University Of Utah · R01 · FY2020 · AI
TARGETING AML-STROMAL INTERACTIONS
$471,871John F Dipersio · Washington University · R01 · FY2013 · CA
HTLV-1 Particle Analysis and Gag Interactions
$471,633Louis M Mansky · University Of Minnesota · R01 · FY2017 · GM
Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection
$471,626Christian L. Boutwell · Massachusetts General Hospital · R01 · FY2024 · AI
Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection
$471,626Todd M Allen · Massachusetts General Hospital · R37 · FY2023 · AI
Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection
$471,626Christian L. Boutwell · Massachusetts General Hospital · R01 · FY2025 · AI
Pathology Resource Network
$471,616Carl D Morrison · Roswell Park Cancer Institute Corp · P30 · FY2012 · CA
Regulation of Normal and Pathogenic B Cell Proliferation by a c-Myc-initiated Transcription Factor Cascade
$471,521Takeshi Egawa · Washington University · R01 · FY2017 · AI
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment
$471,490Kristina K. Hardy · Children'S Research Institute · R01 · FY2017 · CA
Regulation of Hematopoietic Progenitors by de novo DNA Methylation
$471,483Margaret Goodell · Baylor College Of Medicine · R01 · FY2014 · DK
Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia
$471,419Penelope J Duerksen-Hughes · Loma Linda University · R01 · FY2020 · CA
Discovery and Optimization of AML Prognostic Biomarkers
$471,360Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
The role of DNA-PKcs in DNA repair, lymphocyte development, RNA metabolism and tumor suppression
$471,356Shan Zha · Columbia University Health Sciences · R01 · FY2024 · CA
Novel role of an aquaporin in endosome biogenesis and Notch signaling
$471,264Mark E Fortini · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Identification and characterization of new mutants affecting Notch trafficking
$471,264Mark E Fortini · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-operative Treatment Trials
$471,263Nola M. Hylton · University Of California, San Francisco · R01 · FY2010 · CA
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells
$471,218Stella T Chou · Children'S Hosp Of Philadelphia · R01 · FY2015 · DK
Novel Epigenetic Approaches in AML
$471,094James E Bradner · Brigham And Women'S Hospital · P01 · FY2018 · CA
Novel Epigenetic Approaches in AML
$471,092James E Bradner · Brigham And Women'S Hospital · P01 · FY2016 · CA
Novel Epigenetic Approaches in AML
$471,092James E Bradner · Brigham And Women'S Hospital · P01 · FY2017 · CA
Novel Epigenetic Approaches in AML
$471,079James E Bradner · Brigham And Women'S Hospital · P01 · FY2015 · CA
From Research to Clinic: Addressing Ethical and Policy Challenges Facing the Gene Therapy Ecosystem
$471,003Karen Joann Maschke · Hastings Center, Inc. · R01 · FY2025 · HG
Epidemiology of Cancer in a Cohort of Older Women
$470,967Kimberly Z Robien · University Of Minnesota · R01 · FY2010 · CA
Targeting NAMPT in Acute Myeloid Leukemia
$470,916Rosa Lapalombella · Ohio State University · R01 · FY2020 · CA